Organogenesis Holdings (NASDAQ: ORGO) officer disposes shares for taxes

Rhea-AI Filing Summary

Organogenesis Holdings Inc. reported insider tax-related share dispositions by Chief Administrative and Legal Officer Lori Freedman. On February 15, 2026, she executed four Form 4 code F transactions in Class A common stock, delivering 4,043, 24,428, 12,761 and 13,510 shares at $3.73 per share to cover tax liabilities. Following these non-open-market transactions, she held 791,717 shares directly.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Freedman Lori

Role Chief Admin. and Legal Officer

Type	Security	Shares	Price	Value
Tax Withholding	Class A Common Stock	4,043	$3.73	$15K
Tax Withholding	Class A Common Stock	24,428	$3.73	$91K
Tax Withholding	Class A Common Stock	12,761	$3.73	$48K
Tax Withholding	Class A Common Stock	13,510	$3.73	$50K

Holdings After Transaction: Class A Common Stock — 842,416 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Freedman Lori

(Last) (First) (Middle)

C/O ORGANOGENESIS HOLDINGS INC.

85 DAN ROAD

(Street)

CANTON MA 02021

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Organogenesis Holdings Inc. [ ORGO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Admin. and Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/15/2026		F		4,043	D	$3.73	842,416	D
Class A Common Stock	02/15/2026		F		24,428	D	$3.73	817,988	D
Class A Common Stock	02/15/2026		F		12,761	D	$3.73	805,227	D
Class A Common Stock	02/15/2026		F		13,510	D	$3.73	791,717	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Stacie S. Aarestad, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ORGO executive Lori Freedman report?

Lori Freedman reported four insider transactions disposing of Class A common stock to cover tax liabilities. These were Form 4 code F events, meaning shares were delivered to satisfy tax obligations rather than sold in open-market trades, reflecting administrative rather than discretionary selling activity.

How many Organogenesis (ORGO) shares were used for Lori Freedman’s tax withholding?

Lori Freedman used several blocks of shares—4,043, 24,428, 12,761 and 13,510—to satisfy tax withholding. All transactions involved Class A common stock and were coded F, indicating payment of tax liability by delivering shares instead of using cash for the required tax payment.

What price was used for Lori Freedman’s ORGO tax-withholding share dispositions?

Each of Lori Freedman’s tax-withholding dispositions used a price of $3.73 per share. This single price applied across all four Class A common stock transactions reported, which were recorded as Form 4 code F events associated with covering tax obligations, not as traditional open-market stock sales.

What is Lori Freedman’s Organogenesis (ORGO) share balance after these transactions?

After the final tax-withholding transaction, Lori Freedman directly held 791,717 shares of Organogenesis Class A common stock. This balance reflects her position following the last Form 4 code F disposition on February 15, 2026, and represents her remaining direct ownership stake reported in the filing.

What does Form 4 transaction code F mean for ORGO insider activity?

Transaction code F on Form 4 indicates payment of an exercise price or tax liability by delivering securities. For Organogenesis, Lori Freedman used shares of Class A common stock to satisfy tax obligations, so these dispositions are administrative tax-withholding events, not discretionary open-market purchases or sales.